Axiom Therapeutics
PrivateLast Round
Seed
Aug 11, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Axiom Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2025.
Axiom Therapeutics is a biotechnology company that develops a computational platform using machine learning and physics simulations to design covalent drugs for undruggable targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axiom Therapeutics Comparables
Compare Axiom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| COHEAD Therapeutics | 87% | |
| Kuano | 87% | |
| Ternary Therapeutics | 84% |
For institutional investors. Book with your work email.
Axiom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 11, 2026 | ||||
| Seed | Mar 11, 2025 | ||||
| Accelerator | Apr 1, 2024 | ||||
| Grant | Sep 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axiom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed |
| Cambridge Enterprise Ventures | Seed |
| Samos Investments | Seed |
| Innovate UK | Grant |
| Cambridge Enterprise | Seed |
| Entrepreneurs First | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
$12.3M raised in Seed Round.
- Jul 24, 2026
Monthly visitors increased 77% MoM.
For institutional investors. Book with your work email.
Axiom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axiom Therapeutics's valuation, stock price, and market status.
Is Axiom Therapeutics a public or private company?
Axiom Therapeutics is a private company.
What is the current stock price of Axiom Therapeutics?
Axiom Therapeutics is a private company, so its shares have no public market price. Caplight tracks Axiom Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axiom Therapeutics worth (valuation)?
Valuation information for Axiom Therapeutics is not publicly available.
Can I buy Axiom Therapeutics stock?
Axiom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axiom Therapeutics's last funding round?
Axiom Therapeutics's most recent funding round was Seed on August 11, 2026.
Who are the main investors in Axiom Therapeutics?
Key investors in Axiom Therapeutics include Verve Ventures, Cambridge Enterprise Ventures, Samos Investments, Innovate UK, Cambridge Enterprise.
Will Axiom Therapeutics IPO soon?
No public IPO plans have been announced for Axiom Therapeutics.
How can I track Axiom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Axiom Therapeutics's shares on secondary markets.